| Symbol | CLNN |
|---|---|
| Name | CLENE INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 6550 SOUTH MILLROCK DRIVE,SUITE G50, SALT LAKE CITY, Utah, 84121, United States |
| Telephone | +1 801 - 676-9695 |
| Fax | — |
| — | |
| Website | https://www.clene.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001822791 |
| Description | Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Additional info from NASDAQ: |
Director Kiernan Matthew 🟢 acquired 3.2K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027973
Read moreDirector Desai Arjun JJ 🟢 acquired 3.7K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027971
Read moreDirector Mosca Alison 🟢 acquired 4.9K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027970
Read moreDirector MATLIN DAVID J 🟢 acquired 6.2K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027968
Read moreDirector Jacobovitz Shalom 🟢 acquired 4.8K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027967
Read moreDirector Gay Jonathon 🟢 acquired 3.8K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027966
Read moreDirector McLaughlin Vallerie 🟢 acquired 3.5K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027965
Read moreDirector WILCOX REED N 🟢 acquired 3.5K shares (1 derivative) of Clene Inc. (CLNN) at $4.19 Transaction Date: Aug 13, 2026 | Filing ID: 027964
Read moreNew Form SCHEDULE 13G/A - Clene Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001213900-26-089980 <b>Size:</b> 17 KB
Read more